# Double Knockdown of the Androgen Receptor Target Genes DKK1 and SFRP1 Does Not Potentiate the Hair Growth-Promoting Effect of SFRP1 Silencing in Healthy Human Hair Follicles Ex Vivo

**Authors:** David Broadley, Alizée Le Riche, Ying Yu, Helene El-Bacha, Hanieh Erdmann, Francisco Jimenez, Mikhail Geyfman, Neil Poloso, Janin Edelkamp, Marta Bertolini

PMC · DOI: 10.3390/ijms27041815 · International Journal of Molecular Sciences · 2026-02-13

## TL;DR

This study shows that silencing SFRP1 promotes hair growth, but combining it with DKK1 silencing does not improve the effect in human hair follicles.

## Contribution

The study reveals that DKK1 and SFRP1 have compensatory regulation, and combined knockdown does not enhance hair growth benefits.

## Key findings

- SFRP1 knockdown prolonged anagen and increased hair matrix keratinocyte proliferation.
- DKK1 knockdown had no effect on hair growth, and combined knockdown did not enhance SFRP1's benefits.
- Compensatory regulation between DKK1 and SFRP1 highlights Wnt-signaling complexity in hair growth.

## Abstract

Androgen receptor (AR) signaling plays a key role in male pattern baldness. We investigated whether targeting Dickkopf 1 (DKK1) and Secreted frizzled-related protein 1 (SFRP1), two AR-regulated genes, offers a novel therapeutic strategy for hair loss. AR expression was validated in freshly frozen human scalp hair follicles (HFs). AR knockdown was induced in human HFs using AR spherical nucleic acid (SNA). DKK1 and SFRP1 siRNA treatment were performed in HEK293 cells, human dermal papilla cells (hDPC), and human HFs ex vivo. Functional effects of single and combined DKK1 and SFRP1 knockdown were analyzed in human HFs ex vivo by quantitative (immuno)histomorphology. AR knockdown decreased SFRP1 and DKK1 expression. We found reciprocal mRNA upregulation between DKK1 and SFRP1 following their siRNA knockdown in HEK293 and hDPC. We therefore applied a single and combined treatment of DKK1 and SFRP1 siRNA in HFs ex vivo. SFRP1 knockdown prolonged anagen, increased hair matrix keratinocyte proliferation, reduced apoptosis, and increased DKK1 levels in HFs ex vivo, whereas DKK1 knockdown had no effect, and combined knockdown did not enhance SFRP1’s benefits. The culture-dependent compensatory regulation of SFRP1 and DKK1 underscores Wnt-signaling complexity in hair growth and strengthens the rationale for SFRP1 based therapies in anagen maintenance and hair loss.

## Linked entities

- **Genes:** AR (androgen receptor) [NCBI Gene 367], DKK1 (dickkopf Wnt signaling pathway inhibitor 1) [NCBI Gene 22943], SFRP1 (secreted frizzled related protein 1) [NCBI Gene 6422]
- **Diseases:** male pattern baldness (MONDO:0005339)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, SRPRA (SRP receptor subunit alpha) [NCBI Gene 6734] {aka DP, SRPR, Sralpha}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, AXIN2 (axin 2) [NCBI Gene 8313] {aka AXIL, ODCRCS}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, PPIB (peptidylprolyl isomerase B) [NCBI Gene 5479] {aka CYP-S1, CYPB, HEL-S-39, OI9, SCYLP}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, LEF1 (lymphoid enhancer binding factor 1) [NCBI Gene 51176] {aka ECTD1, ECTD17, LEF-1, TCF10, TCF1ALPHA, TCF7L3}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, WNT10B (Wnt family member 10B) [NCBI Gene 7480] {aka SHFM6, STHAG8, WNT-12}, DVL1P1 (dishevelled segment polarity protein 1 pseudogene 1) [NCBI Gene 8215] {aka DVL-22, DVL1L1}, B2M (beta-2-microglobulin) [NCBI Gene 567] {aka AMYLD6, IMD43, MHC1D4}, Sfrp1 (secreted frizzled-related protein 1) [NCBI Gene 20377] {aka 2210415K03Rik, sFRP-1}, Dntt (deoxynucleotidyltransferase, terminal) [NCBI Gene 21673] {aka Tdt}, Dkk1 (dickkopf WNT signaling pathway inhibitor 1) [NCBI Gene 13380] {aka mdkk-1}, DKK1 (dickkopf Wnt signaling pathway inhibitor 1) [NCBI Gene 22943] {aka DKK-1, SK}, HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 3172] {aka FRTS4, HNF4, HNF4a7, HNF4a8, HNF4a9, HNF4alpha}, UNC5C (unc-5 netrin receptor C) [NCBI Gene 8633] {aka UNC5H3}, SFRP1 (secreted frizzled related protein 1) [NCBI Gene 6422] {aka FRP, FRP-1, FRP1, FrzA, SARP2}, CXXC5 (CXXC finger protein 5) [NCBI Gene 51523] {aka CF5, HSPC195, RINF, WID}
- **Diseases:** HFs (MESH:D006201), hypertrichosis (MESH:D006983), injury to (MESH:D014947), Male pattern hair loss (MESH:D000505)
- **Chemicals:** Alexa Fluor 488 (MESH:C000711379), H2O2 (MESH:D006861), ApopTag (-), Digoxigenin (MESH:D004076), G-418 (MESH:C010680), cyclosporine (MESH:D016572), penicillin (MESH:D010406), Hematoxylin (MESH:D006416), Finasteride (MESH:D018120), Eosin (MESH:D004801), PBS (MESH:D007854), NADH (MESH:D009243), DHT (MESH:D013196), DAPI (MESH:C007293), CO2 (MESH:D002245), L-Glutamine (MESH:D005973), PFA (MESH:C003043), melanin (MESH:D008543), hydrocortisone (MESH:D006854), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), rhodamine (MESH:D012235), biotin (MESH:D001710), testosterone (MESH:D013739), TRIzol (MESH:C411644)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), hDPC — Mus musculus (Mouse), Transformed cell line (CVCL_WK43), HFs — Homo sapiens (Human), Hairy cell leukemia, Cancer cell line (CVCL_B401), HEK293 STF — Homo sapiens (Human), Transformed cell line (CVCL_AQ26), HF — Homo sapiens (Human), Diffuse large B-cell lymphoma germinal center B-cell type, Cancer cell line (CVCL_UI84)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940833/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940833/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940833/full.md

---
Source: https://tomesphere.com/paper/PMC12940833